Amethyst Austria Advances AI-Supported Radiotherapy with TheraPanacea

Amethyst Radiotherapy Austria, part of Stingray Healthcare, has introduced two artificial intelligence (AI) solutions from TheraPanacea, strengthening its radiotherapy planning and adaptive treatment capabilities.

The integration of TumorBox and AdaptBox into clinical practice represents another step in the centre’s adoption of advanced radiotherapy technology. Both solutions support clinical teams in treatment planning, monitoring anatomical changes and making informed decisions throughout a patient’s treatment.

Improving Radiotherapy Planning with Artificial Intelligence

Accurate treatment planning is essential in radiotherapy, ensuring radiation is delivered precisely to the target area while limiting exposure to surrounding healthy tissues.

TumorBox, TheraPanacea’s AI-powered contouring solution, supports this process by automatically identifying and outlining tumours and nearby organs on medical images.

Traditionally, contouring requires considerable manual work, particularly in complex cases. By automating parts of this process, TumorBox helps improve planning efficiency and provides clinicians with a consistent starting point for developing individual treatment plans.

All AI-generated contours are reviewed by qualified clinical specialists, ensuring that medical expertise remains central to treatment decisions.

Supporting Adaptive Radiotherapy with AdaptBox

During a course of radiotherapy, a patient’s anatomy can change due to factors such as tumour response, organ movement or changes in body weight.

AdaptBox helps clinical teams assess these changes using images acquired during treatment. The technology can generate synthetic CT images, identify relevant anatomical structures and support recalculation of the radiation dose.

This provides clinicians with additional information to evaluate whether anatomical changes could affect treatment delivery and whether adjustments to the original plan should be considered.

By supporting adaptive radiotherapy, AdaptBox helps specialists assess treatment plans in response to changes throughout a patient’s treatment journey.

Combining AI Technology with Clinical Expertise

The introduction of TumorBox and AdaptBox demonstrates how artificial intelligence can support radiotherapy professionals by streamlining complex planning tasks and providing additional information for clinical decision-making.

At Amethyst Radiotherapy Austria, these technologies are used alongside the expertise of radiation oncologists, medical physicists and radiotherapy professionals, who remain responsible for all clinical decisions.

As part of Stingray Healthcare’s European network, Amethyst Austria continues to strengthen its clinical capabilities through the adoption of advanced technology, reflecting the Group’s commitment to supporting high-quality, patient-centred cancer care.